/Investor DB

Sage Venture Partners — Full Portfolio

4 tracked investments · listed companies and verified rows first

Flowlieflowlie.comin𝕏✓ verified

Quill (operated by Flowlie Technologies) provides a managed back-office function that unifies finance, HR, compliance, capital planning, and board preparation for startup founders.

Enterprise SoftwareFintechFuture of WorkHR TechSaaS

Kaben Clauson(Co-Founder & CEO)Ian Cohen(Co-Founder & CEO)Rick Gordon(Co-Founder & CEO)Adam Stepanovic(Co-Founder & CEO)Philip Odelfelt(Co-Founder & CEO)inVlad Cazacu(Founder)in

Co-investorsBaseLayer VenturesBright Pixel CapitalEPIC VENTURESGeek VenturesGlasswing VenturesSQUADRA VENTURES+4 more

FinTronfintroninvest.com𝕏Sep 2022

FinTron (operating under Apex) provides Ascend Investor, a white-label and API-first digital wealth management platform that lets banks, retirement platforms, and financial institutions add self-directed brokerage, robo investing, and hybrid advisory services without building from scratch.

Enterprise SoftwareFintechSaaSStamford, US

Wilder Rumpf(Founder)in

Co-investorsConnecticut InnovationsAUA Capital ManagementWebster Bank

Recuro Healthrecurohealth.comin𝕏Mar 2021

Recuro is a virtual-first digital health platform that provides primary care, behavioral health, urgent care, and supplemental benefits (pharmacy, care management, advocacy) to patients, employers, health plans, and providers.

Digital HealthHealthtechSaaSRichardson, US

Michael Brombach(Chief Executive Officer and Co-Founder)inMichael Gorton(Chief Executive Officer)inDr. Kate Sowerwine(Chief Medical Officer)John Halsey(Director)Kris Engskov(Director)inWilliam Paiva(Director)

Co-investors1843 Capital4D CapitalARCH Venture PartnersCortado VenturesCure VenturesGlobal Insurance Accelerator+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Defense Mobile

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.